Treatment Considerations and Safety Updates in Metastatic Pancreatic Adenocarcinoma
Treatment Considerations and Safety Updates in Metastatic Pancreatic Adenocarcinoma

Rahul Gosain, MD, MBA, Rohit Gosain, MD

Advances in Pancreatic and Biliary Tract Cancers at ASCO GI 2026: Expert Insights
Advances in Pancreatic and Biliary Tract Cancers at ASCO GI 2026: Expert Insights

Anupriya Singhal, MD, PhD

Pancreatic Cancer Highlights From ASCO GI 2026
Pancreatic Cancer Highlights From ASCO GI 2026

Fiyinfolu Balogun, MD, PhD, Angelo Pirozzi, MD

Optimal Frontline Treatment in Metastatic Pancreatic Cancer
Optimal Frontline Treatment in Metastatic Pancreatic Cancer

Raji Shameem, MD, Rohit Gosain, MD

Molecular Profiling Expands Treatment Options in Pancreatic and Biliary Tract Cancers
Molecular Profiling Expands Treatment Options in Pancreatic and Biliary Tract Cancers

Dina Ioffe, MD, Shubham Pant, MD, MBBS

Pancreatic Cancer in 2025: Nearing an Inflection Point
Pancreatic Cancer in 2025: Nearing an Inflection Point

Udhayvir Singh Grewal, MD

Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy
Latest GI Cancer Trends From ASCO 2025: Molecular Testing, IO Strategies & Targeted Therapy

Seyi Abidoye, MBBS, Lisa Liu, MD

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine
Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MD, Rachna Shroff, MD, MS, FASCO